154 related articles for article (PubMed ID: 30289174)
1. Knowledge regarding and patterns of genetic testing in patients newly diagnosed with breast cancer participating in the iCanDecide trial.
Gornick MC; Kurian AW; An LC; Fagerlin A; Jagsi R; Katz SJ; Hawley ST
Cancer; 2018 Oct; 124(20):4000-4009. PubMed ID: 30289174
[TBL] [Abstract][Full Text] [Related]
2. Effect of a computer-based decision aid on knowledge, perceptions, and intentions about genetic testing for breast cancer susceptibility: a randomized controlled trial.
Green MJ; Peterson SK; Baker MW; Harper GR; Friedman LC; Rubinstein WS; Mauger DT
JAMA; 2004 Jul; 292(4):442-52. PubMed ID: 15280342
[TBL] [Abstract][Full Text] [Related]
3. Impact of BRCA1/BRCA2 counseling and testing on newly diagnosed breast cancer patients.
Schwartz MD; Lerman C; Brogan B; Peshkin BN; Halbert CH; DeMarco T; Lawrence W; Main D; Finch C; Magnant C; Pennanen M; Tsangaris T; Willey S; Isaacs C
J Clin Oncol; 2004 May; 22(10):1823-9. PubMed ID: 15067026
[TBL] [Abstract][Full Text] [Related]
4. Uptake, Results, and Outcomes of Germline Multiple-Gene Sequencing After Diagnosis of Breast Cancer.
Kurian AW; Ward KC; Hamilton AS; Deapen DM; Abrahamse P; Bondarenko I; Li Y; Hawley ST; Morrow M; Jagsi R; Katz SJ
JAMA Oncol; 2018 Aug; 4(8):1066-1072. PubMed ID: 29801090
[TBL] [Abstract][Full Text] [Related]
5. Randomized trial of proactive rapid genetic counseling versus usual care for newly diagnosed breast cancer patients.
Schwartz MD; Peshkin BN; Isaacs C; Willey S; Valdimarsdottir HB; Nusbaum R; Hooker G; O'Neill S; Jandorf L; Kelly SP; Heinzmann J; Zidell A; Khoury K
Breast Cancer Res Treat; 2018 Aug; 170(3):517-524. PubMed ID: 29611029
[TBL] [Abstract][Full Text] [Related]
6. Utilization of BRCA1/BRCA2 mutation testing in newly diagnosed breast cancer patients.
Schwartz MD; Lerman C; Brogan B; Peshkin BN; Isaacs C; DeMarco T; Halbert CH; Pennanen M; Finch C
Cancer Epidemiol Biomarkers Prev; 2005 Apr; 14(4):1003-7. PubMed ID: 15824179
[TBL] [Abstract][Full Text] [Related]
7. Attitudes, knowledge, risk perceptions and decision-making among women with breast and/or ovarian cancer considering testing for BRCA1 and BRCA2 and their spouses.
Bluman LG; Rimer BK; Regan Sterba K; Lancaster J; Clark S; Borstelmann N; Iglehart JD; Winer EP
Psychooncology; 2003; 12(5):410-27. PubMed ID: 12833555
[TBL] [Abstract][Full Text] [Related]
8. BRCAPRO validation, sensitivity of genetic testing of BRCA1/BRCA2, and prevalence of other breast cancer susceptibility genes.
Berry DA; Iversen ES; Gudbjartsson DF; Hiller EH; Garber JE; Peshkin BN; Lerman C; Watson P; Lynch HT; Hilsenbeck SG; Rubinstein WS; Hughes KS; Parmigiani G
J Clin Oncol; 2002 Jun; 20(11):2701-12. PubMed ID: 12039933
[TBL] [Abstract][Full Text] [Related]
9. Improving Breast Cancer Surgical Treatment Decision Making: The iCanDecide Randomized Clinical Trial.
Hawley ST; Li Y; An LC; Resnicow K; Janz NK; Sabel MS; Ward KC; Fagerlin A; Morrow M; Jagsi R; Hofer TP; Katz SJ
J Clin Oncol; 2018 Mar; 36(7):659-666. PubMed ID: 29364772
[TBL] [Abstract][Full Text] [Related]
10. Impact of educational print materials on knowledge, attitudes, and interest in BRCA1/BRCA2: testing among Ashkenazi Jewish women.
Schwartz MD; Benkendorf J; Lerman C; Isaacs C; Ryan-Robertson A; Johnson L
Cancer; 2001 Aug; 92(4):932-40. PubMed ID: 11550168
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of decision aids for female BRCA1 and BRCA2 mutation carriers: a systematic review.
Krassuski L; Vennedey V; Stock S; Kautz-Freimuth S
BMC Med Inform Decis Mak; 2019 Aug; 19(1):154. PubMed ID: 31370837
[TBL] [Abstract][Full Text] [Related]
12. Risk estimation as a decision-making tool for genetic analysis of the breast cancer susceptibility genes. EC Demonstration Project on Familial Breast Cancer.
Chang-Claude J; Becher H; Caligo M; Eccles D; Evans G; Haites N; Hodgson S; Møller P; Weber BH; Stoppa-Lyonnet D
Dis Markers; 1999 Oct; 15(1-3):53-65. PubMed ID: 10595253
[TBL] [Abstract][Full Text] [Related]
13. Randomized noninferiority trial of telephone versus in-person genetic counseling for hereditary breast and ovarian cancer.
Schwartz MD; Valdimarsdottir HB; Peshkin BN; Mandelblatt J; Nusbaum R; Huang AT; Chang Y; Graves K; Isaacs C; Wood M; McKinnon W; Garber J; McCormick S; Kinney AY; Luta G; Kelleher S; Leventhal KG; Vegella P; Tong A; King L
J Clin Oncol; 2014 Mar; 32(7):618-26. PubMed ID: 24449235
[TBL] [Abstract][Full Text] [Related]
14. Systematic review of the empirical investigation of resources to support decision-making regarding BRCA1 and BRCA2 genetic testing in women with breast cancer.
Grimmett C; Pickett K; Shepherd J; Welch K; Recio-Saucedo A; Streit E; Seers H; Armstrong A; Cutress RI; Evans DG; Copson E; Meiser B; Eccles D; Foster C
Patient Educ Couns; 2018 May; 101(5):779-788. PubMed ID: 29225062
[TBL] [Abstract][Full Text] [Related]
15. Information needs of mothers regarding communicating BRCA1/2 cancer genetic test results to their children.
Tercyak KP; Peshkin BN; Demarco TA; Patenaude AF; Schneider KA; Garber JE; Valdimarsdottir HB; Schwartz MD
Genet Test; 2007; 11(3):249-55. PubMed ID: 17949286
[TBL] [Abstract][Full Text] [Related]
16.
Concolino P; Gelli G; Rizza R; Costella A; Scambia G; Capoluongo E
Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31336956
[TBL] [Abstract][Full Text] [Related]
17. Predictors of knowledge and knowledge gain after decision aid use among women with BRCA1/2 pathogenic variants.
Lautz Z; Kautz-Freimuth S; Shukri A; Redaèlli M; Rhiem K; Schmutzler R; Stock S
Patient Educ Couns; 2024 Jul; 124():108248. PubMed ID: 38513456
[TBL] [Abstract][Full Text] [Related]
18. Randomized trial of a decision aid for BRCA1/BRCA2 mutation carriers: impact on measures of decision making and satisfaction.
Schwartz MD; Valdimarsdottir HB; DeMarco TA; Peshkin BN; Lawrence W; Rispoli J; Brown K; Isaacs C; O'Neill S; Shelby R; Grumet SC; McGovern MM; Garnett S; Bremer H; Leaman S; O'Mara K; Kelleher S; Komaridis K
Health Psychol; 2009 Jan; 28(1):11-19. PubMed ID: 19210013
[TBL] [Abstract][Full Text] [Related]
19. How should we discuss genetic testing with women newly diagnosed with breast cancer? Design and implementation of a randomized controlled trial of two models of delivering education about treatment-focused genetic testing to younger women newly diagnosed with breast cancer.
Watts KJ; Meiser B; Mitchell G; Kirk J; Saunders C; Peate M; Duffy J; Kelly PJ; Gleeson M; Barlow-Stewart K; Rahman B; Friedlander M; Tucker K;
BMC Cancer; 2012 Jul; 12():320. PubMed ID: 22838957
[TBL] [Abstract][Full Text] [Related]
20. Key messages for communicating information about BRCA1 and BRCA2 to women with breast or ovarian cancer: Consensus across health professionals and service users.
Jacobs C; Pichert G; Harris J; Tucker K; Michie S
Psychooncology; 2017 Nov; 26(11):1818-1824. PubMed ID: 28101941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]